申请人:Imperial Chemical Industries PLC
公开号:US04454157A1
公开(公告)日:1984-06-12
The invention relates to a pharmaceutical composition comprising a tetracyclononane derivative of the formula: ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are hydrogen atoms or alkyl radicals and A is CH.sub.2 CH.sub.2 or CH--R.sup.4 in which R.sup.4 is a hydrogen atom or an alkyl, cyclohexyl, phenylalkyl or optionally-substituted phenyl radical, or a salt thereof. The majority of compounds of the formula II are novel and they are included within the scope of the invention, as are processes for their manufacture. Typical of the compounds disclosed is 8-(1-amino-ethyl)tetracyclo[4,3,0,0.sup.2,4,0.sup.3,7 ]nonane.
本发明涉及一种药物组合物,包括式为:##STR1## 的四环素九烷衍生物,其中R.sup.1,R.sup.2和R.sup.3是氢原子或烷基基团,A是CH.sub.2 CH.sub.2或CH--R.sup.4,其中R.sup.4是氢原子或烷基、环己基、苯基烷基或可选取代的苯基基团,或其盐。公式II的大部分化合物都是新的,并且它们被包括在本发明的范围内,包括它们的制造方法。所披露的化合物的典型例子是8-(1-氨基乙基)四环[4,3,0,0.sup.2,4,0.sup.3,7 ]九烷。